LIXT / Lixte Biotechnology Holdings, Inc. - Net Long/Short Value

Lixte Biotechnology Holdings, Inc.
US ˙ NasdaqCM ˙ US5393193017

LIXT / Lixte Biotechnology Holdings, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
UBS Group AG
Raymond James Financial Inc
VEXMX - VANGUARD INDEX FUNDS - Vanguard Extended Market Index Fund Investor Shares
Bank Of America Corp /de/
Clear Street Llc
Ethos Financial Group, LLC
FCFMX - FIDELITY CONCORD STREET TRUST - Fidelity Series Total Market Index Fund
Tower Research Capital LLC (TRC)
Atlas Legacy Advisors, LLC
Geode Capital Management, Llc
FNCMX - FIDELITY CONCORD STREET TRUST - Fidelity Nasdaq Composite Index Fund
SBI Securities Co., Ltd.
HighTower Advisors, LLC
FSMAX - FIDELITY CONCORD STREET TRUST - Fidelity Extended Market Index Fund
Other Listings
DE:8640
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista